|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Cash and due from banks: | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Interest-bearing deposits | |||||||||||||||||||
| Total cash and cash equivalents | |||||||||||||||||||
| Available-for-sale securities, at fair value (Note 3) | |||||||||||||||||||
| Held-to-maturity securities, net of allowance for credit losses of $210 at June 30, 2026 and $236 at December 31, 2025; at amortized cost (fair value at June 30, 2026 $246,965 and at December 31. 2025 $268,875) (Note 3) | |||||||||||||||||||
| Placement with banks | |||||||||||||||||||
| Mortgage loans held for sale, at fair value (Note 4) | |||||||||||||||||||
| Loans receivable, net of allowance for credit losses of $24,664 at March 31, 2024 and $26,154 at December 31, 2023 (Note 5) | |||||||||||||||||||
| Loans receivable, net of allowance for credit losses of $27,554 at June 30, 2026 and $25,449 at December 31, 2025 (Note 5) | |||||||||||||||||||
| Accrued interest receivable | |||||||||||||||||||
| Premises and equipment, net | |||||||||||||||||||
| Right of use assets (Note 6) | |||||||||||||||||||
| Federal Home Loan Bank of New York (FHLBNY) stock, at cost | |||||||||||||||||||
| Federal Reserve Bank of New York (FRBNY) stock, at cost | |||||||||||||||||||
| Deferred tax assets | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||||||||
| Liabilities: | |||||||||||||||||||
| Deposits (Note 7) | |||||||||||||||||||
| Borrowings (Note 8) | |||||||||||||||||||
| Operating lease liabilities | |||||||||||||||||||
| Accrued interest payable | |||||||||||||||||||
| Advance payments by borrowers for taxes and insurance | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders' Equity: | |||||||||||||||||||
| Preferred stock, $0.01 par value; 100,000,000 shares authorized: Series A, senior non-cumulative perpetual, $1,000 per share liquidation preference, 225,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | |||||||||||||||||||
| Common stock, $0.01 par value; 200,000,000 shares authorized; 24,886,711 shares issued at both June 30, 2026 and December 31, 2025; 24,187,901 shares outstanding as of June 30, 2026 and 24,135,926 shares outstanding as of December 31, 2025 | |||||||||||||||||||
| Treasury stock, at cost; 698,810 shares as of June 30, 2026 and 750,785 shares as of December 31, 2025 | |||||||||||||||||||
| Additional paid-in-capital | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Accumulated other comprehensive loss (Note 13) | |||||||||||||||||||
| Unearned compensation - ESOP; 1,101,372 shares as of June 30, 2026 and 1,168,244 shares as of December 31, 2025 | |||||||||||||||||||
| Total stockholders' equity | |||||||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||||||
Loading...
